(Q38265002)

English

Role of vascular inflammation in coronary artery disease: potential of anti-inflammatory drugs in the prevention of atherothrombosis. Inflammation and anti-inflammatory drugs in coronary artery disease

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 September 2017

1 reference

Europe PubMed Central

Role of vascular inflammation in coronary artery disease: potential of anti-inflammatory drugs in the prevention of atherothrombosis. Inflammation and anti-inflammatory drugs in coronary artery disease (English)

1 reference

Europe PubMed Central

1 September 2017

0 references

coronary artery disease

1 reference

based on heuristic

inferred from title

author name string

Daniel Medeiros Moreira

1

1 reference

Europe PubMed Central

1 September 2017

Roberto Leo da Silva

2

1 reference

Europe PubMed Central

1 September 2017

Jefferson Luís Vieira

3

1 reference

Europe PubMed Central

1 September 2017

Tammuz Fattah

4

1 reference

Europe PubMed Central

1 September 2017

Maria Emilia Lueneberg

5

1 reference

Europe PubMed Central

1 September 2017

Carlos Antonio Mascia Gottschall

6

1 reference

Europe PubMed Central

1 September 2017

publication date

1 February 2015

1 reference

Europe PubMed Central

1 September 2017

American journal of cardiovascular drugs

1 reference

Europe PubMed Central

1 September 2017

15

1 reference

Europe PubMed Central

1 September 2017

1

1 reference

Europe PubMed Central

1 September 2017

1-11

1 reference

Europe PubMed Central

1 September 2017

https://scigraph.springernature.com/pub.10.1007/s40256-014-0094-z

0 references

Heart disease and stroke statistics--2014 update: a report from the American Heart Association

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, a

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Innate and adaptive immunity in the pathogenesis of atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Acute-phase proteins and other systemic responses to inflammation

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Interleukin-6 and the acute phase response

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Identification of an inducible endothelial-leukocyte adhesion molecule

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

The response-to-retention hypothesis of early atherogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

The oxidation hypothesis of atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Low density lipoprotein oxidation and its pathobiological significance

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Inflammation and coagulation in atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Heat shock protein 60 and immune inflammatory responses in atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

C5a-induced expression of P-selectin in endothelial cells

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro. Comparison with secretion of interleukin 1 beta and interleukin 1 alpha

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Immunobiology of dendritic cells

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Ultrastructural recognition of cells with dendritic cell morphology in human aortic intima. Contacting interactions of Vascular Dendritic Cells in athero-resistant and athero-prone areas of the normal aorta.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Endothelial determinants of dendritic cell adhesion and migration: new implications for vascular diseases

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Lymphocytes are important in early atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

The expanding universe of T-cell subsets: Th1, Th2 and more.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Adaptive immunity in atherogenesis: new insights and therapeutic approaches

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Cytotoxic and proinflammatory CD8+ T lymphocytes promote development of vulnerable atherosclerotic plaques in apoE-deficient mice

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Current understanding of the role of B cell subsets and intimal and adventitial B cells in atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Peripheral B cell subsets

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

The peritoneal cavity provides a protective niche for B1 and conventional B lymphocytes during anti-CD20 immunotherapy in mice.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

B cell depletion reduces the development of atherosclerosis in mice

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

BAFF receptor deficiency reduces the development of atherosclerosis in mice--brief report.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Depletion of B2 but not B1a B cells in BAFF receptor-deficient ApoE mice attenuates atherosclerosis by potently ameliorating arterial inflammation

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Pro-inflammatory genetic markers of atherosclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

A variant in the ABO gene explains the variation in soluble E-selectin levels-results from dense genotyping in two independent populations

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

A genome-wide association scan on the levels of markers of inflammation in Sardinians reveals associations that underpin its complex regulation

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Regulation of intercellular adhesion molecule-1 (ICAM-1) in ischemic and reperfused canine myocardium

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Relationship of admission neutrophil count to microvascular injury, left ventricular dilation, and long-term outcome in patients treated with primary angioplasty for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Evidence for an active inflammatory process in the hibernating human myocardium

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Anti-inflammatory effects of simvastatin in subjects with hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Effect of cyclosporine on reperfusion injury in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Colchicine update: 2008.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Low-dose colchicine for secondary prevention of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Inhibition of 5-aminoimidazole-4-carboxamide ribotide transformylase, adenosine deaminase and 5'-adenylate deaminase by polyglutamates of methotrexate and oxidized folates and by 5-aminoimidazole-4-carboxamide riboside and ribotide

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5'-nucleotidase-mediated conversion of adenine nucleotides

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Methotrexate and MX-68, a new derivative of methotrexate, limit infarct size via adenosine-dependent mechanisms in canine hearts.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Treatment with methotrexate inhibits atherogenesis in cholesterol-fed rabbits

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Anti-atherogenic effects of methotrexate carried by a lipid nanoemulsion that binds to LDL receptors in cholesterol-fed rabbits

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

The effects of METhotrexate therapy on the physical capacity of patients with ISchemic heart failure: a randomized double-blind, placebo-controlled trial (METIS trial).

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Rationale and design of the TETHYS trial: the effects of methotrexate therapy on myocardial infarction with ST-segment elevation.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Effects of interleukin-1β inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Effects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failu

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Pexelizumab in ischemic heart disease: a systematic review and meta-analysis on 15,196 patients

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Treatment with 5-lipoxygenase inhibitor VIA-2291 (Atreleuton) in patients with recent acute coronary syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

The complement component C5a is present in human coronary lesions in vivo and induces the expression of MMP-1 and MMP-9 in human macrophages in vitro

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Complement regulation in human atherosclerotic coronary lesions

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Identifiers

10.1007/S40256-014-0094-Z

1 reference

Europe PubMed Central

1 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

1 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38265002&oldid=1751452751"